Sebastien Ribault
Corporate Officer/Principal at OXFORD BIOMEDICA PLC
Profile
Sebastien Ribault is currently the Chairman at Merck Biodevelopment SAS, Director at Cell-Easy SAS (starting in 2023), and Chief Commercial Officer at Oxford Biomedica Plc (starting in 2022).
Previously, he worked as the Head of Research & Development Laboratory at Hemosystem SA. He obtained a doctorate degree from the University of Strasbourg.
Sebastien Ribault active positions
Companies | Position | Start |
---|---|---|
OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 2021-12-31 |
Merck Biodevelopment SAS
Merck Biodevelopment SAS Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Merck Biodevelopment SAS engages in research and development in other physical and natural sciences. The company is based in Lyon, France. The CEO of the French company is Didier Rosenberger. | Chairman | - |
Cell-Easy SAS
Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France. | Director/Board Member | 2023-05-10 |
Former positions of Sebastien Ribault
Companies | Position | End |
---|---|---|
Hemosystem SA
Hemosystem SA Medical SpecialtiesHealth Technology Hemosystem SA developed technologies to improve safety in the blood transfusion. The company was founded by Jean-Pierre Hermet in May 1999 and was headquartered in Marseille, France. | Corporate Officer/Principal | - |
Training of Sebastien Ribault
University of Strasbourg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
OXFORD BIOMEDICA PLC | Health Technology |
Private companies | 3 |
---|---|
Hemosystem SA
Hemosystem SA Medical SpecialtiesHealth Technology Hemosystem SA developed technologies to improve safety in the blood transfusion. The company was founded by Jean-Pierre Hermet in May 1999 and was headquartered in Marseille, France. | Health Technology |
Merck Biodevelopment SAS
Merck Biodevelopment SAS Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Merck Biodevelopment SAS engages in research and development in other physical and natural sciences. The company is based in Lyon, France. The CEO of the French company is Didier Rosenberger. | Commercial Services |
Cell-Easy SAS
Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France. | Commercial Services |
- Stock Market
- Insiders
- Sebastien Ribault